Analyst consensus rating
Intensity Therapeutics Analyst Rating: none
Direct answer
Intensity Therapeutics's consensus rating is none.
6 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $19.33.
Forecast evidence checked October 2, 2026.
Get free Intensity Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $3.29
- Average price target
- $19.33
- High price target
- $32.00
- Low price target
- $7.00
- Low target gap
- +112.8%
- Target upside
- +487.6%
- High target gap
- +872.6%
- Target range width
- 759.9%
- Consensus rating
- none
- Analysts
- 6
- Evidence date
- October 2, 2026
- Valid through
- October 9, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Intensity Therapeutics?
Intensity Therapeutics has a verified none consensus. The same dataset has an average price target of $19.33.
How far are Intensity Therapeutics's low and high targets from the recorded price?
The low target implies +112.8%, while the high target implies +872.6%.
How many analysts are included in Intensity Therapeutics's consensus?
The verified consensus includes 6 analysts.
How is Intensity Therapeutics's target upside or downside calculated?
The average target of $19.33 is divided by the recorded price of $3.29, then one is subtracted to produce +487.6%. This does not guarantee a future return.
When was Intensity Therapeutics's analyst forecast verified?
The data was verified on 2026-10-02. The dataset is valid through 2026-10-09.